PIEZO1 and central nervous system cancer: Both bioinformatics and clinical data showed that Piezo1 expression was upregulated in all histological subtypes of glioma, from LGG to GBM, and that its expression was positively correlated with malignancy (Chen et al., 2018; Zhou et al., 2020).